...
首页> 外文期刊>Helminthologia >Regression of alveolar echinococcosis after chronic viral hepatitis C treatment with pegylated interferon alpha 2a.
【24h】

Regression of alveolar echinococcosis after chronic viral hepatitis C treatment with pegylated interferon alpha 2a.

机译:用聚乙二醇化干扰素α2a治疗慢性丙型病毒性肝炎后肺泡棘球co病的消退。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We present a case of 53 years old patient with transplanted kidney, chronic hepatitis C and alveolar echinococcosis who was treated with pegylated interferon alpha which resulted in regression and calcification of Echinococcus multilocularis loculi. Patient had been diagnosed with chronic hepatitis C two years after kidney transplantation. Hepatitis was left untreated because of immunosuppressive treatment and satisfactory graft function. Nine years after transplantation the patient was diagnosed with alveolar echinococcosis and treated with mebendazole 2x200 mg daily for 6 months. Cessation of temporary treatment resulted in echinococcosis progression with appearance of secondary loculi and a small ascites after which mebendazole was restarted. Ten years after transplantation, kidney graft failure occurred and the patient was started on hemodialysis in conjunction with pegylated-interferon alpha 2a for treatment of chronic viral hepatitis C. Complete early viral response was observed 3 months after therapy initiation while a follow-up CT scan after 4 months did not document any changes in the number or size of E. multilocularis loculi. A completed course of antiviral therapy resulted in sustained viral response while a subsequent second follow-up CT scan 6 months after cessation of antiviral therapy documented regression and calcification of main E. multilocularis loculi along with resolution of secondary loculi and ascites.
机译:我们提出了一例53岁的移植肾,慢性丙型肝炎和肺泡棘球cc病的患者,该患者接受了聚乙二醇化干扰素α的治疗,导致多发棘球loc球的消退和钙化。肾脏移植两年后被诊断为慢性丙型肝炎。由于免疫抑制治疗和令人满意的移植功能,肝炎得不到治疗。移植九年后,该患者被诊断出肺泡棘球co虫病,并每天服用甲苯咪唑2x200 mg治疗6个月。停止临时治疗会导致棘球ech虫病进展,并伴有继发性尺和少量腹水,然后重新开始使用甲苯达唑。移植十年后,发生肾移植失败,患者开始接受血液透析和聚乙二醇干扰素α2a联合治疗慢性丙型肝炎。开始治疗后3个月,观察到完全的早期病毒反应,同时进行了后续CT扫描4个月后,没有记录到多叶大肠杆菌的数量或大小有任何变化。一个完整的抗病毒治疗过程导致了持续的病毒反应,而在停止抗病毒治疗后的6个月进行了后续的第二次CT扫描,记录了主要的多眼葡萄球虫病灶的消退和钙化,以及继发性病灶和腹水的消退。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号